Matches in SemOpenAlex for { <https://semopenalex.org/work/W2956556575> ?p ?o ?g. }
Showing items 1 to 87 of
87
with 100 items per page.
- W2956556575 endingPage "950" @default.
- W2956556575 startingPage "944" @default.
- W2956556575 abstract "Abstract Background Few studies have examined complementary medicine (CM) use in diabetes. Australian data are inconsistent, limited in scope and have not considered cost. Aims To evaluate the prevalence, associates and costs of CM in a contemporary Australian urban, community‐based cohort of people with type 2 diabetes. Methods Baseline CM use was determined as part of a detailed assessment in 1543 of 1551 Fremantle Diabetes Study Phase II (FDS2) participants with type 2 diabetes (mean age 65.7 years, 51.8% males, median diabetes duration 9.0 years) recruited to the FDS2 between 2008 and 2011 who self‐reported medication use including CM defined as non‐prescription medicinal products. Results A total of 672 FDS2 type 2 participants (43.6%) used at least one type of CM, 92% of which were nutritional supplements (omega‐3 fatty acids/fish oil in 24% of CM users followed by calcium in 11%, glucosamine in 10% and others in <10%). Independent associates of CM use included older age, female sex, any mobility problem, and, inversely, Southern European or Indigenous Australian background, lack of English fluency, ex/current smoking status, taking oral glucose‐lowering medications and higher HbA 1c . The total annual estimated cost of CM used by FDS2 participants with type 2 diabetes was A$121 640 or A$79 ± 208 per person (range A$0–2993). Extrapolating these data, the 1 million Australians with type 2 diabetes spend A$79 million/year on CM. Conclusions CM use in type 2 diabetes is both common and costly. Healthcare professionals should consider discussing safe and cost‐effective use of CM with their patients with type 2 diabetes." @default.
- W2956556575 created "2019-07-23" @default.
- W2956556575 creator A5007637089 @default.
- W2956556575 creator A5024425448 @default.
- W2956556575 creator A5032570051 @default.
- W2956556575 creator A5042994367 @default.
- W2956556575 creator A5043791621 @default.
- W2956556575 creator A5060608228 @default.
- W2956556575 date "2020-08-01" @default.
- W2956556575 modified "2023-10-15" @default.
- W2956556575 title "Complementary medicine use and its cost in Australians with type 2 diabetes: the Fremantle Diabetes Study Phase II" @default.
- W2956556575 cites W1741721665 @default.
- W2956556575 cites W1921253240 @default.
- W2956556575 cites W1969045525 @default.
- W2956556575 cites W2009788308 @default.
- W2956556575 cites W2032912132 @default.
- W2956556575 cites W2034838252 @default.
- W2956556575 cites W2051228110 @default.
- W2956556575 cites W2092240209 @default.
- W2956556575 cites W2115079411 @default.
- W2956556575 cites W2144203881 @default.
- W2956556575 cites W2147222003 @default.
- W2956556575 cites W2155798421 @default.
- W2956556575 cites W2323243553 @default.
- W2956556575 cites W2334742474 @default.
- W2956556575 cites W2613946146 @default.
- W2956556575 cites W2791052070 @default.
- W2956556575 cites W285926761 @default.
- W2956556575 cites W2899669642 @default.
- W2956556575 cites W2903332820 @default.
- W2956556575 cites W2922388296 @default.
- W2956556575 cites W4239349741 @default.
- W2956556575 doi "https://doi.org/10.1111/imj.14437" @default.
- W2956556575 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31314167" @default.
- W2956556575 hasPublicationYear "2020" @default.
- W2956556575 type Work @default.
- W2956556575 sameAs 2956556575 @default.
- W2956556575 citedByCount "3" @default.
- W2956556575 countsByYear W29565565752020 @default.
- W2956556575 countsByYear W29565565752021 @default.
- W2956556575 crossrefType "journal-article" @default.
- W2956556575 hasAuthorship W2956556575A5007637089 @default.
- W2956556575 hasAuthorship W2956556575A5024425448 @default.
- W2956556575 hasAuthorship W2956556575A5032570051 @default.
- W2956556575 hasAuthorship W2956556575A5042994367 @default.
- W2956556575 hasAuthorship W2956556575A5043791621 @default.
- W2956556575 hasAuthorship W2956556575A5060608228 @default.
- W2956556575 hasConcept C126322002 @default.
- W2956556575 hasConcept C134018914 @default.
- W2956556575 hasConcept C144024400 @default.
- W2956556575 hasConcept C149923435 @default.
- W2956556575 hasConcept C2777180221 @default.
- W2956556575 hasConcept C555293320 @default.
- W2956556575 hasConcept C71924100 @default.
- W2956556575 hasConcept C72563966 @default.
- W2956556575 hasConcept C74909509 @default.
- W2956556575 hasConceptScore W2956556575C126322002 @default.
- W2956556575 hasConceptScore W2956556575C134018914 @default.
- W2956556575 hasConceptScore W2956556575C144024400 @default.
- W2956556575 hasConceptScore W2956556575C149923435 @default.
- W2956556575 hasConceptScore W2956556575C2777180221 @default.
- W2956556575 hasConceptScore W2956556575C555293320 @default.
- W2956556575 hasConceptScore W2956556575C71924100 @default.
- W2956556575 hasConceptScore W2956556575C72563966 @default.
- W2956556575 hasConceptScore W2956556575C74909509 @default.
- W2956556575 hasFunder F4320334705 @default.
- W2956556575 hasIssue "8" @default.
- W2956556575 hasLocation W29565565751 @default.
- W2956556575 hasOpenAccess W2956556575 @default.
- W2956556575 hasPrimaryLocation W29565565751 @default.
- W2956556575 hasRelatedWork W1563850031 @default.
- W2956556575 hasRelatedWork W2045367862 @default.
- W2956556575 hasRelatedWork W2074686124 @default.
- W2956556575 hasRelatedWork W2233866314 @default.
- W2956556575 hasRelatedWork W2315085516 @default.
- W2956556575 hasRelatedWork W2316407790 @default.
- W2956556575 hasRelatedWork W2415759662 @default.
- W2956556575 hasRelatedWork W2603773853 @default.
- W2956556575 hasRelatedWork W2964295425 @default.
- W2956556575 hasRelatedWork W3036934084 @default.
- W2956556575 hasVolume "50" @default.
- W2956556575 isParatext "false" @default.
- W2956556575 isRetracted "false" @default.
- W2956556575 magId "2956556575" @default.
- W2956556575 workType "article" @default.